Faculty of Medicine and Health, The University of Sydney School of Public Health, Sydney, New South Wales, Australia
ARC Centre for Excellence in Population Ageing Research (CEPAR), University of Sydney, Sydney, New South Wales, Australia.
BMJ Open. 2020 Dec 22;10(12):e040959. doi: 10.1136/bmjopen-2020-040959.
The Mediterranean diet has been promoted as a healthy dietary pattern, but whether the Mediterranean diet may help to prevent hepatic steatosis is not clear. This study aimed to evaluate the prospective association between adherence to the Mediterranean diet and risk of hepatic steatosis.
Population-based prospective cohort study.
The Swiss CoLaus Study.
We evaluated 2288 adults (65.4% women, aged 55.8±10.0 years) without hepatic steatosis at first follow-up in 2009-2012. Adherence to the Mediterranean diet was scaled as the Mediterranean diet score (MDS) based on the Mediterranean diet pyramid ascertained with responses to Food Frequency Questionnaires.
New onset of hepatic steatosis was ascertained by two indices separately: the Fatty Liver Index (FLI, ≥60 points) and the non-alcoholic fatty liver disease (NAFLD) score (≥-0.640 points). Prospective associations between adherence to the Mediterranean diet and risk of hepatic steatosis were quantified using Poisson regression.
During a mean 5.3 years of follow-up, hepatic steatosis was ascertained in 153 (6.7%) participants by FLI criteria and in 208 (9.1%) by NAFLD score. After multivariable adjustment, higher adherence to MDS was associated with lower risk of hepatic steatosis based on FLI: risk ratio 0.84 (95% CI 0.73 to 0.96) per 1 SD of MDS; 0.85 (0.73 to 0.99) adjusted for BMI; and 0.85 (0.71 to 1.02) adjusted for both BMI and waist circumference. When using NAFLD score, no significant association was found between MDS and risk of hepatic steatosis (0.95 (0.83 to 1.09)).
A potential role of the Mediterranean diet in the prevention of hepatic steatosis is suggested by the inverse association observed between adherence to the Mediterranean diet and incidence of hepatic steatosis based on the FLI. The inconsistency of this association when hepatic steatosis was assessed by NAFLD score points to the need for accurate population-level assessment of fatty liver and its physiological markers.
地中海饮食已被宣传为一种健康的饮食模式,但地中海饮食是否有助于预防肝脂肪变性尚不清楚。本研究旨在评估地中海饮食与肝脂肪变性风险之间的前瞻性关联。
基于人群的前瞻性队列研究。
瑞士科洛伊斯研究。
我们评估了 2288 名成年人(65.4%为女性,年龄 55.8±10.0 岁),他们在 2009-2012 年首次随访时没有肝脂肪变性。地中海饮食的依从性通过基于地中海饮食金字塔的地中海饮食评分(MDS)来衡量,该评分是通过食物频率问卷的回答得出的。
通过两个指数分别确定新发生的肝脂肪变性:脂肪肝指数(FLI,≥60 分)和非酒精性脂肪性肝病(NAFLD)评分(≥-0.640 分)。采用泊松回归定量评估地中海饮食与肝脂肪变性风险之间的前瞻性关联。
在平均 5.3 年的随访期间,根据 FLI 标准,153 名(6.7%)参与者和 208 名(9.1%)参与者被确定为肝脂肪变性。在多变量调整后,MDS 得分越高,肝脂肪变性的风险越低:每增加 1 个 MDS 的 SD,FLI 的风险比为 0.84(95%CI 0.73 至 0.96);调整 BMI 后为 0.85(0.73 至 0.99);调整 BMI 和腰围后为 0.85(0.71 至 1.02)。当使用 NAFLD 评分时,MDS 与肝脂肪变性的风险之间没有显著关联(0.95(0.83 至 1.09))。
基于 FLI,观察到地中海饮食与肝脂肪变性发生率之间的负相关关系,提示地中海饮食可能在预防肝脂肪变性方面发挥作用。当使用 NAFLD 评分评估肝脂肪变性时,这种关联的不一致表明需要对人群中肝脂肪变性及其生理标志物进行准确评估。